Modulation of T-regulatory cells by small molecules: potential therapy for GvHD
Allogeneic haematopoietic stem cell transplantation (alloHSCT) is often curative for patients suffering from blood cancers. Nonetheless, significant morbidity and mortality are still prevalent. One major complication is graft versus host disease (GvHD) which occurs in 30-70% of patients. In this dis...
Autor principal: | Leuschner, U |
---|---|
Outros Autores: | Roberts, D |
Formato: | Tese |
Idioma: | English |
Publicado em: |
2021
|
Registros relacionados
-
Cellular Strategies for Separating GvHD from GvL in Haploidentical Transplantation
por: Mauro Di Ianni, et al.
Publicado em: (2024-01-01) -
The Role of Bacteria and Pattern Recognition Receptors in GvHD
por: E. Holler, et al.
Publicado em: (2010-01-01) -
Fibroblastic reticular cells mitigate acute GvHD via MHCII-dependent maintenance of regulatory T cells
por: Haroon Shaikh, et al.
Publicado em: (2022-11-01) -
Bone marrow GvHD after allogeneic hematopoietic stem cell transplantation
por: Martin eSzyska, et al.
Publicado em: (2016-03-01) -
Immunometabolic Therapeutic Targets of Graft-versus-Host Disease (GvHD)
por: Kudakwashe Mhandire, et al.
Publicado em: (2021-10-01)